skip to main content

ProfessionalsKyle T. Seifried

Kyle T. Seifried

Tel: +1-212-373-3220
Fax: +1-212-492-0220

New York

1285 Avenue of the Americas
New York, NY 10019-6064
Fax: +1-212-492-0220

Bar Admissions 
Bar Admissions 

Kyle Seifried is a counsel in the Corporate Department and a member of the firm’s Mergers & Acquisitions Group. His practice focuses on public and private company acquisitions and divestitures, leveraged buyouts (representing private equity sponsors, companies and management groups), cross-border transactions and securities transactions. Kyle also regularly advises clients on activist defense, corporate governance and compliance matters, federal and state reporting obligations, takeover preparedness and other significant corporate matters. Additionally, Kyle has advised numerous investment banking clients in transactional and financial advisory work. He is recognized in Chambers USA for his work on Corporate/M&A.


Kyle’s representations include advising:

  • Bioverativ in its acquisition by Sanofi
  • Chevron in its proposed acquisition of Anadarko Petroleum
  • CSRA in its acquisition by General Dynamics
  • IBM in its acquisition of Red Hat
  • ILG in its sale to Marriott Vacations Worldwide
  • Midstates Petroleum Company in its proposal to combine with SandRidge Energy

Kyle was involved in numerous notable transactions prior to joining Paul, Weiss, including advising:

  • BAI Brands in its acquisition by Dr Pepper Snapple Group
  • Bally Technologies in its sale to Scientific Games Corporation
  • Centene Corp. in its acquisition of Health Net
  • Danaher Corporation in its acquisition of Pall Corporation
  • Express Scripts in its:
    • acquisition of Medco Health Solutions
    • acquisition of WellPoint’s NextRX subsidiaries
  • Google in its acquisition of Apigee
  • Landis+Gyr in its sale to Toshiba Corporation
  • Marubeni Corporation in its acquisition of Gavilon Group
  • News Corporation in its acquisition of Dow Jones
  • Norfolk Southern Corporation in connection with an unsolicited offer and threatened proxy contest by Canadian Pacific Railway
  • Permira Funds in:
    • the sale of its portfolio company, Arysta LifeScience Limited, to Platform Specialty Products Corporation
    • its sale of Iglo Foods Holding Ltd. to Nomad Holdings
  • Representaciones e Investigaciones Médicas S.A. de C.V. (Rimsa) in its acquisition by Teva Pharmaceutical Industries Limited
  • SHFL entertainment in its sale to Bally Technologies
  • The Hershey Company in connection with an unsolicited offer from Mondelēz International
  • Univision Communications in its sale to a consortium of private equity investors
  • Video Game Technologies in its sale to Aristocrat Leisure
  • WMS Industries in its sale to Scientific Games Corporation

© 2019 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy